Wang, Jianjie, and Virginia H. Huxley. Adenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeability. Am J Physiol Heart Circ Physiol 291: H3094 -H3105, 2006. First published June 30, 2006 doi:10.1152/ajpheart.00526.2006Little is known of the regulation of skeletal muscle microvascular exchange under resting or stimulating conditions. Adenosine (ADO) levels in skeletal muscle increase during physiological (exercise) and pathological (hypoxia, inflammation, and ischemia) conditions. Later stages of these pathologies are characterized by the loss of vascular barrier integrity. This study focused on determining which ADO receptor mediates the robust reduction in microvessel permeability to rat serum albumin (P s RSA ) observed in juvenile female rats. In microvessels isolated from abdominal skeletal muscle, ADO suffusion induced a concentration-dependent reduction in arteriolar [log(IC 50) 
SKELETAL MUSCLE MICROVESSELS have a large capacity to vasodilate and increase blood flow, thereby increasing oxygen and nutrient supply during exercise (7) . During whole body dynamic exercise at maximal oxygen consumption, skeletal muscle receives 85-90% of cardiac output (11) compared with 20% at rest. Adenosine (ADO), a ubiquitous adenine nucleoside, was shown to be a key vasodilator in skeletal muscles under physiological and pathophysiological conditions including hypoxia (5) , ischemia, and muscle contraction (8, 22, 23, 34) . Furthermore, ADO was found, from measures of permeability-surface area product (13) , to increase skeletal muscle microvasculature blood-tissue exchange, an increase believed to be secondary to the increased exchange surface area downstream from the arterioles dilating in response to ADO (1, 6, 7, 14) . It is unclear, however, whether ADO itself could modulate skeletal muscle permeability. The feedback mechanism of skeletal muscle myocyte contraction resulting in ADO production, which can regulate blood flow through smooth muscle dilatation thereby enhancing substrate delivery, led us to hypothesize that ADO could also regulate substrate transport by altering directly exchange skeletal muscle vessel barrier function.
The notion that microvascular exchange is a dynamic process has arisen from studies in a variety of microvascular models including frog (27) and rat (46) mesentery and pig heart (29) . Despite the need for understanding the mechanisms controlling the distribution of substrates and wastes in this major tissue, little is known, given the difficulty of assessing flux and permeability in a thick tissue. The majority of what is known of in vivo microvascular exchange has come from the study of thin tissues (e.g., mesentery, cheek pouch, cremaster muscle) more suitable to the limitations of light microscopy. In this study, vascular trees were isolated from a skeletal muscle present in female animals; once isolated, an individual microvessel segment was perfused with micropipettes, and solute flux was measured using fluorescent dye-labeled probes by microspectrofluorometry (26) .
In earlier studies of isolated coronary microvessels from a combined group of sexually mature sedentary male and female pigs, ADO was found to reduce arteriolar permeability (P s ) to albumin via activation of ADO A 1 and/or A 2A receptors. While the same receptors were shown to be present in coronary venules, ADO appeared to be without effect on venular P s (56) . Expansion of the data set, facilitating analysis of the venule data by sex, demonstrated that, in fact, ADO decreased P s of venules from males and increased P s of venules from females (29) . Recent preliminary studies in rats (28) demonstrated that P s responses to ADO depended on vessel type, maturity, and sex. In skeletal muscle microvessels from juvenile females, the response to ADO was a robust reduction in permeability to rat serum albumin (P s RSA ), leading us to use this model as a first test of our hypotheses in this study: P s RSA responses to ADO differ between abdominal skeletal muscle arterioles and venules.
Responses to ADO appear to be modulated by activation of four ADO receptor subtypes (A 1 , A 2A , A 2B , and A 3 ), cloned from a variety of species, linked to different second messenger systems leading subsequently to functionally distinct end points (16) . ADO-induced changes in vascular tone (magnitude, duration, and direction) differ with respect to the species, tissue, and receptor subtypes. In pig heart, ADO causes vasodilation primarily via activation of A 2A receptors (2, 4, 20) , although A 1 , A 2A , and A 2B receptors are expressed in coronary vasculature (21, 41) . In mice, ADO-induced coronary vasodilatation is mediated by a combination of A 1 and/or A 3 receptors (53, 54) . In rat skeletal muscle, vasodilatation responses to ADO are mediated primarily via A 2A and/or A 1 receptors (6, 10, 38) . In the present study, therefore, a variety of available pharmacological tools and molecular approaches were used in addition to assessment of barrier function to test our second hypothesis: that acute changes in P s RSA responses to ADO are the consequence of the combined involvement of the ADO receptor subtypes, which differ between skeletal muscle arterioles and venules of juvenile female rats.
MATERIALS AND METHODS
Experimental animals and microvessel preparation. All animal care and research was conducted in accordance with the National Research Council's "Guide for the Care and Human Use of Laboratory Animals" under protocols approved by the Office of Laboratory Medicine at the University of Missouri. Studies were carried out on 77 sexually immature female (40) Sprague-Dawley rats (Յ40 days of age, 100 -150 g; Hilltop Lab Animals, Scottsdale, PA). Rats were anesthetized with an intraperitoneal injection of 130 mg/kg thiobutabarbital (Inactin; Sigma, St. Louis, MO). Following removal of fur and skin from the anterior abdomen, the abdominal wall muscle was excised carefully and placed in cold (4°C) mammalian Krebs solution containing 0.15 mM dialyzed bovine serum albumin (BSA; Sigma).
Dissection of the microvessels from the rat abdominal skeletal muscle was modified from that for porcine coronary ventricle (30) . A dissecting microscope (Zeiss, Thornwood, NY) aided in the isolation procedure from the excised abdominal wall muscle (40 -50 ϫ 30 -40 mm). An arteriolar plexus, dissected from the internal surface of the abdominal muscle (transversus abdominis muscle), contained arterioles Ͻ100 m in internal diameter (ID) that branched from larger feed arteries arising from the cranial or caudal epigastric artery. Given that arterioles and venules in skeletal muscle run in parallel, isolation of the arteriolar plexus resulted in isolation of a venular plexus. The venules were distinguished from the arterioles by the absence of a muscular wall and larger resting diameter. These plexuses were mounted at approximately their in vivo resting length gently on a Sylgard (Dow Corning, Midland, MI) pad over the surface of an inverted organ culture dish and kept submersed in Krebs-albumin.
Measurement of skeletal muscle microvessel permeability. The plexus was transilluminated and viewed at ϫ10 with a fixed-stage inverted microscope (Diavert, Leica, or Olympus IX70). The light path of the microscope was split 50/50 and projected simultaneously to a video system and an analog microscope photometer (PTI, Brunswick, NJ). Vessels were imaged using a black and white chargecoupled device (CCD) camera (Dage-MTI 72, Michigan City, IN) or a low-light camera (PTI) and displayed on a video monitor (projecting a field of view of 0.65 ϫ 0.78 to 1.30 ϫ 1.56 mm; Sony). A pseudocolor picture was generated using NIH Image software (National Institutes of Health, Bethesda, MD)
Single microvessels in the plexus were cannulated with a drawn and beveled (tip diameter 20 Ϯ 5 m) glass theta micropipette (WPI, Sarasota, FL) that contained an unlabeled washout solution [rat serum albumin (RSA) in Krebs, 10 mg/ml] in one-half of the pipette and fluorescent dye-labeled RSA (see below) in the lumen of the other half.
Fluorescence intensity (I f) from the microvessel lumen and surrounding vessel wall was defined by an adjustable rectangular window in the light path (3D ϫ 2D, width ϫ length). The photometer output S, cm 2 ) and constant concentration gradient (⌬C, mmol/cm 3 ) (Js/S⌬C, cm/s) was determined from the relationship
where ⌬I o is the fluorescence intensity of the test solute in the microvessel lumen, (dIf/dt)i is the initial change in fluorescence intensity as solute moves across the vessel wall, and D is microvessel diameter (cm). For each measurement of P s, the vessel was first perfused with unlabeled RSA for at least 1 min; the perfusate was then switched rapidly to labeled RSA, Js was measured during 2 min of perfusion with the labeled RSA, and the perfusate was returned back to unlabeled RSA. This perfusion sequence was repeated at least three times so that recording was continued for at least 9 min for each condition. All measurements were carried out at 15°C and a low hydrostatic pressure of 15 cmH 2O in arterioles and 12 cmH2O in venules to maintain constant microvessel tone (thereby minimizing changes in diameter) and to minimize the contribution of convective coupling (solvent drag) to the measure of net flux (30) , respectively. Earlier studies demonstrated that working at the lower temperature was without significant effect on the magnitude of P s and, more importantly, the direction of the Ps response to ADO or other reagents studied to date (33) . Calculations of Ps took into account steady-state changes in diameter.
Experimental protocols. All of the tested solutions were applied to the vessel topically. Basal permeability to RSA (P s con ) was measured during perfusion with dye-labeled RSA (10 mg/ml) and superfused with Krebs-BSA (1 mg/ml). P s was then measured again in the presence of ADO or ADO analogs-Krebs-BSA suffusion following pretreatment with ADO or ADO analogs suffusion for 10 min. To assess P s dose responses, increasing concentrations of ADO or ADO analogs were applied continuously in the suffusate. If the analogs were dissolved in DMSO, the suffusate under control conditions contained DMSO at the same concentration. In experiments where the impact of the ADO receptor antagonist on ADO or ADO analoginduced P s RSA responses was determined, Ps was measured with Krebs-BSA suffusate containing both agonist and antagonist after P s RSA had been measured during Krebs-BSA suffusion without and with antagonist.
Mammalian Krebs solution. The components of this solution included the following (in mM): 141.4 NaCl, 4.7 KCl, 2 CaCl 2 ⅐ H2O, 1.2 MgSO 4, 1.2 NaH2PO4 ⅐ H2O, 5 glucose, 3 NaHCO3, and 1.5 HEPES. The pH and osmolarity of the solution were 7.40 Ϯ 0.05 and 294 (292-298) mosM, respectively, at room temperature.
Krebs-serum albumin solutions. BSA was prepared for the suffusion solution, while RSA was prepared for perfusion solution. For stock solutions of BSA or RSA (Sigma), the protein was dissolved in double-distilled water (ddH 2O) at a concentration of 100 mg/ml. Diafiltration was performed in an Amicon Stirred Cell (Millipore) through a 30,000 Nominal Molecular Weight Limit (NMWL; Millipore) filter with a volume of glucose-free Krebs equal to three times the volume of the albumin solution. The concentration of the dialyzed protein was determined by absorbance spectroscopy at 280 nm and then adjusted to a 100 mg/ml stock solution, aliquoted, and stored at Ϫ20°C. All solutions containing albumin at a 10 mg/ml final concentration were prepared and used daily.
Fluorescent dye-labeled albumin. Skeletal muscle microvessel protein flux was detected using RSA labeled with a red fluorescent dye, Alexa Fluor-546 (Molecular Probes, Eugene, OR). Alexa Fluor-546 and RSA (3:1, molar/molar; starting concentration 0.125 M albumin) were mixed and reacted for 30 min at room temperature, followed by removal of free fluorescent dye with D-Salt Polyacrylamide Desalting Columns (Pierce, IL). The perfusate consisted of 1 part conjugated RSA and 9 parts unlabeled, dialyzed RSA (wt/wt) in Krebs at a final concentration of RSA of 10 mg/ml.
Reagents. All ADO agonists and antagonists (Sigma) used are provided in Table 1 .
RT-PCR. Extraction of mRNA from single isolated arterioles and venules (ID Ͻ100 M, 1-2 mm in length) using paramagnetic oligo(dT) polystyrene beads [Dynabeads Oligo(dT) 25 ; Dynal, Carlsbad, CA] was described previously (57) . In brief, individual isolated microvessels were homogenized in LiCl lysis buffer. The crude lysate and magnetic beads were incubated for 15 min at room temperature. The beads were washed two to three times with 100 l of solutions A [10 mM Tris ⅐ HCl, pH 7.5, 150 mM LiCl, 1 mM EDTA, 0.1% CH 3(CH2)11OSO3 Li (wt/vol)] and B (10 mM Tris ⅐ HCl, pH 7.5, 150 mM LiCl, 1 mM EDTA), respectively. The mRNA was eluted from the beads by addition of 10 l of RNase-free H 2O. Rat brain homogenate was used as a positive control for ADO receptors (16) . Total RNA from rat brain was extracted using RNAgents Total RNA Isolation System (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Following digestion of DNA to oligonucleotides with DNase I (Promega, Madison, WI), first-strand cDNA synthesis from microvessel mRNA and rat brain total RNA was conducted using reverse transcriptase Sensiscript RT kit (Qiagen, Valencia, CA). Primers for specific ADO receptors are shown in Table 2 . Complementary DNA amplification was performed using HotStarTaq DNA polymerase in accordance with the manufacturer's instructions (Qiagen). PCR for ADO A 1, A2A, A2B, and A3 receptors was conducted for 40 -43 cycles at 94°C for 45 s (denature), 60°C for 1 min (anneal), and 72°C for 1 min (extension) following an initial denaturation step of 95°C for 15 min. A final extension of 72°C for 10 min was added after the 43rd amplification cycle. PCR products were separated by electrophoresis through 2% (wt/vol) agarose gel and visualized under UV light with ethidium bromide.
Immunoblot analysis. The expression of ADO receptor protein in arterioles and venules isolated from the juvenile female rat abdominal skeletal muscle was assessed by immunoblot analysis as described previously (57) . In brief, each sample consisted of one to two arterioles or venules (ID Ͻ100 m, 1 mm in length) homogenized in solubilization buffer [50 mM Tris ⅐ HCl (pH ϭ 7.4), 6 M urea, and 2% SDS (vol/vol) (47)]; the cell lysates were subjected to SDS-PAGE [10% (wt/vol) for A 2A and A2B, 12% for A1 and A3], and protein was transferred to a polyvinylidene difluoride (PVDF) membrane. The membrane was probed with specific polyclonal antibodies for ADO receptors (Table 3 ) and incubated with secondary antibody (horseradish peroxidase-conjugated IgG; 1:1,000 dilution for A 1 and A3, 1:1,500 dilution for A2B, and 1:4,000 dilution for A2A receptor detection; Pierce, Rockford, IL). Protein was detected by enhanced chemiluminescence (SuperSignal West Dura Extended Duration Substrate; Pierce). Specificity of antibodies for ADO A 1, A2A, and A2B receptors was confirmed by control antigenic peptide competition. Antigenic peptides for A 1, A2A, and A2B were preabsorbed with their respective primary antibodies overnight at 4°C [antibody-peptide (vol/vol), according to the manufacturer's instructions; A 1 ϭ 1:1, A2A ϭ 1:10, and A2B ϭ 1:10] and used as control for primary antibodies to show blockade of ADO receptor immunoreactivity. A3 receptor antibody specificity was tested by using rabbit ␥-globulin (1:200 dilution; Jackson ImmunoResearch Laboratories) instead of A 3 receptor antiserum as the primary antibody to perform immunoblot ( Fig. 1, top) . To monitor protein loading, monocolonal antibodies for ␤-tubulin (1:10,000; Chemicon, Temecula, CA) and ␤-actin (1:1,000; Santa Cruz Biotechnology, Santa Cruz, CA) were incubated with PVDF membrane in the presence of ADO receptor antibody.
Immunofluorescence assay. The cellular distribution of ADO A 1, A 2A, A2B, and A3 receptors in arterioles and venules in situ was determined using dual-color immunofluorescence and confocal laserscanning microscopy. Cryostat sections (7-m thick) of abdominal skeletal muscle were fixed in methanol-acetone (1:1, Ϫ20°C for 10 min). Sections were washed with 0.1 M PBS (pH 7.4) and blocked with 5% (vol/vol) normal goat serum (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted in PBS for 1 h. Sections were then incubated with dual primary antibodies, anti-ADO receptor 
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KD or KB value (equilibrium association constants) was obtained for rats. ADO, adenosine; ddH2O, double-distilled water. *Data for mixed A2. (Table 5) . Therefore, the maintenance of temperature at 15°C had the desired effect of minimizing diameter changes without influencing the effect of ADO on permeability.
Detection of ADO A 1 , A 2A , A 2B , and A 3 receptors. RT-PCR and Western blot analyses of the expression of gene transcripts (messenger RNA) and protein for ADO receptors were conducted on rat skeletal muscle microvessels. Rat brain was employed as a positive control. Figure 3 shows representative RT-PCR analysis of whole individual arterioles and venules isolated from abdominal skeletal muscles. Messenger RNA for A 1 (Fig. 3A) , A 2A (Fig. 3B) , A 2B (Fig. 3C) , and A 3 (Fig. 3D ) was detected in all arterioles and venules. Coexpression of the four ADO receptor subtypes in both arterioles and venules was confirmed by immunoblot analysis. The representative immunoblot analysis for the presence of A 1 (molecular mass ϭ 36 kDa, n ϭ 4), A 2A (molecular mass ϭ 53 kDa for rat brain, molecular mass ϭ 67 kDa for microvessels, n ϭ 6), A 2B (molecular mass ϭ 52 and 40 kDa, n ϭ 6), and A 3 receptor protein (molecular mass ϭ 36 and 30 kDa, n ϭ 3) is shown in Fig. 4 .
Immunofluorescent analysis of abdominal skeletal muscle cross sections and confocal microscopic imaging revealed cellular distribution of ADO A 1 , A 2A , A 2B , or A 3 receptors (antibodies for receptors labeled with Alexa-488, green) with Fig. 2 . ADO concentration-dependent reduction in permeability (to rat serum albumin; P s RSA ). Data are expressed as the ratio of P s RSA during ADO suffusion (P s ADO ) to basal P s RSA (P s con ). A: responses of arterioles (n ϭ 4 -9). B: responses of venules (n ϭ 4 -5). *Significant response to ADO, e.g., the ratio (P s ADO / P s con ) 1 (P Ͻ 0.05). Values are means Ϯ SE. The dashed line represents no change in P s RSA in response to ADO compared with basal P s RSA . Values are mean Ϯ SE. *Significant difference between paired values (P Ͻ 0.05). For abbreviation definitions, see Table 1. highest density in the endothelium and smooth muscle of the arteriolar and venular wall. Contributions of A 1 and A 2 to ADO response. A pharmacological approach was employed to determine which ADO receptor subtypes modulate microvessel P s RSA responses to ADO. At least 10 min of exposure of the microvessel to sufusate containing the nonselective A 1 and A 2 receptor antagonist 8-(p-sulphophenyl)theophylline (8-SPT) at 10 Ϫ5 (n ϭ 6) and 10 Ϫ4 (n ϭ 6) M blocked the reduction in arteriole and venule P s RSA evoked by 10 Ϫ5 M ADO suffusion. The antagonist 8-SPT alone, at these two doses, was without effect on basal P s RSA in both microvessel subtypes shown in Fig. 6 (Fig. 7A : CPA, n ϭ 6; NECA, n ϭ 6) or venule ( Fig.  7B : CPA, n ϭ 5; NECA, n ϭ 7-8; P Ͼ 0.05) P s RSA . CGS21680 caused a dose-dependent reduction of P s RSA in both vessel types (arteriole, n ϭ 3-10; venule, n ϭ 3-7). The values of log(IC 50 ) for P s RSA responses to CGS21680 were Ϫ7.5 Ϯ 1.1 M and Ϫ8.5 Ϯ 0.4 M for arterioles and venules, respectively. The maximal reduction in P s RSA induced by CGS21680 was 45.9 Ϯ 4.8% and 41.0 Ϯ 7.7% of baseline for arterioles and venules, respectively. Both the sensitivity and magnitude of P s RSA responses to CGS21680 between arterioles and venules were indistinguishable ( Table 4) .
Effect of the A 2A receptor antagonist ZM241385. To further determine whether A 2A receptors mediated the CGS21680-induced responses, microvessel P s RSA responses to CGS21680 were measured in the presence of a selective A 2A receptor Fig. 3 . Expression of messenger RNA for ADO A1 (A), A2A (B), A2B (C), and, A3 (D) receptors in both microvessel types isolated from abdominal skeletal muscles of female juvenile rats, demonstrated by RT-PCR. Individual isolated arterioles (Art) and venules (Ven) Ͻ100 m in internal diameter (ID) and 1-2 mm in length were subjected to mRNA extraction, reverse transcription, and amplification with specific ADO A1, A2A, A2B, and A3 primers. Rat brain was used as a positive control. antagonist, ZM241385 (20, 42) . At 10 Ϫ7 M, ZM241385 abolished the fall in arteriolar and venular P s RSA induced by CGS21680 (Fig. 8, A and B) . The vehicle (DMSO; 0.0001%, 1.4 ϫ 10 Ϫ5 M) or 10 Ϫ7 M ZM241385 alone was without effect on basal P s RSA [P s test /P s con ϭ 1.02 (n ϭ 5) and 1.06 (n ϭ 10) for DMSO and ZM241385, respectively]. In addition, ZM241385 blocked the reduction of arteriolar (n ϭ 5) and venular (n ϭ 6) P s RSA induced by 10 Ϫ8 M and 10 Ϫ7 M ADO, respectively (Fig.  8C) .
Reduction of P s in response to ADO mediated by adenylyl cyclase. It is generally accepted that the ADO A 2A receptor is coupled to the G ␣s protein and is able to activate adenylyl cyclase (16) . We therefore used the adenylyl cyclase inhibitor SQ22536 to test whether the cell-signaling mechanism mediating the P s response to ADO was adenylyl cyclase dependent. While basal P s in both vessel types was not influenced by 10 Ϫ5 M SQ22536 (arteriole, P s test /P s con ϭ 1.16 Ϯ 0.13, n ϭ 4; venule, P s test /P s con ϭ 1.15 Ϯ 0.13, n ϭ 4), it abolished the reduction of P s induced by 10 Ϫ8 M and 10 Ϫ7 M ADO for arterioles (n ϭ 4) and venules (n ϭ 4), respectively (Fig. 9) .
DISCUSSION
The present study initiated a test of the hypothesis that P s RSA responses to ADO involve signaling mechanisms regulated by more than one of the ADO receptor subtypes and that differ- ences in responses to ADO between vessel types and tissues and following adaptation to exercise reflect differences in the receptor subtype-signaling pathways. The studies were conducted on skeletal muscle microvessels from juvenile female rats, where we observed a robust reduction in permeability from basal levels during exposure to ADO (28) . The novel findings of the present study with respect to juvenile females are as follows: 1) basal permeability of skeletal muscle arterioles and venules do not differ; 2) ADO suffusion (Յ10 Ϫ5 M) causes a concentration-dependent reduction in P s RSA of both arterioles and venules; 3) both microvessel subtypes express mRNA and protein for the four identified ADO receptor subtypes distributed on the endothelium and vascular smooth muscle; and 4) before reproductive maturity in female rats, the reduction in P s RSA by ADO appears to be mediated primarily through ADO A 2A receptors, which involve adenylyl cyclasemediated mechanisms.
Basal albumin exchange in abdominal skeletal muscle microvessels of juvenile female rats. Although skeletal muscle comprises the largest percentage of total body mass, surprisingly little information is available regarding the permeability characteristics of the microvasculature (55) . The present study is the first to measure P s to albumin in individual perfused microvessels isolated from rat abdominal skeletal muscles. The first result, contrary to expectation (43) , was that basal permeability of venules was not higher than that of the arterioles. Indeed, this outcome is in contrast with that observed in other vascular beds (venular P s Ͼ arteriolar P s ) including adult (29, 57) and juvenile porcine heart (24, 59) and skeletal muscles of adult male rat (48), mouse (48), guinea pig (43), and rabbit (50). The primary difference between the current study and those published previously is that the venous values are significantly lower than reported for other rodent skeletal muscle models (adult male) (57) .
Volume balance results from the interplay of vascular permeability and interstitial resistance to solute flux as well as lymphatic function. Vessel architecture (surface area, number of vessels, vessel length, distance between vessels) and interstitial composition contribute to the interstitial resistance to solute flux. Obviously, the juvenile females are, in solute and volume balance, like the adult male animals, although their venular microvascular resistance (R ϭ 1/P s ) is higher than for the males. Volume balance, however, could be achieved if one or more of the other components were changed, e.g., interstitial resistance was lower and/or lymphatic function was reduced. It remains to be determined whether the lack of an arteriolevenule permeability gradient, reflecting apparently tighter venules, is particular to juvenile and/or female rodents.
In isolated rat hindquarter preparation, the combined permeability-surface area product for albumin was reported to be 0.025 ml⅐min Ϫ1 ⅐100 g Ϫ1 (adult males) (58) . With the assumption of a surface area for exchange of 70 cm 2 /g from cat hindlimb data (58) , this product translates to a P s of 0.6 ϫ 10
Ϫ7
cm/s, a value significantly lower than our findings for apparent P s RSA (9.9 Ϯ 0.4 and 10.7 Ϯ 0.5 ϫ 10 Ϫ7 cm/s for arterioles and venules, respectively). While it is reassuring that these values are within an order of magnitude of each other, several factors likely contribute to the differences in the absolute values. These include errors in the determination of the perfused surface area and differences in experimental preparation (isolated microvessels vs. isolated organ), tissue (abdominal vs. hindquarter), sex (female vs. male), and age (juvenile vs. adult) and the possibility that P s values of vessels packed in an intact tissue are reduced by the presence of the myocytes. cm/s) reported in the current study is almost twice that of venular mesentery P s RSA (45) . Again, it is not known at this time whether this difference (Ref. 45 vs. the current study) reflects differences between tissues (mesentery vs. skeletal muscle), sex (male vs. female), or maturity (adult vs. juvenile). It is interesting to note that the use of the same technique for assessing P s reduces the difference from 10-to 2-fold. Preliminary data from this laboratory (56) indicate that sex and reproductive maturity are both important variables influencing basal permeability and are features requiring additional study.
Regulation of skeletal muscle microvessel P s RSA by ADO. In skeletal muscle, interstitial ADO concentration increases significantly during hypoxia (5), ischemia, and muscle contraction (8, 22, 23, 34) . For instance, in response to extensor exercise, the interstitial ADO in human vastus lateralis muscle increased fivefold from resting levels of 2.2 Ϯ 0.1 ϫ 10 Ϫ7 M at a work rate of 10 W (23). It is well known that, in skeletal muscle, ADO is an important local metabolic vasodilator (6, 14, 39) . In addition to ADO having the capacity to regulate blood flow delivery, and hence exchange, by dilating feed arterioles, ADO has been shown recently to regulate the exchange of protein by mediating permeability changes in coronary microvessels (25, 29, 30, 57) .
In the present study, we found that P s RSA of two vessel types, arterioles and venules, isolated from juvenile female abdominal skeletal muscles was reduced by ADO in a concentrationdependent manner (Fig. 2) . These findings are inconsistent with our global hypothesis that ADO-induced P s RSA responses would differ between arterioles and venules. What did differ with respect to vessel type was that the arteriolar P s RSA response was more sensitive to ADO suffusion than the venular response. The results from the juvenile females are most consistent with ADO acting in the two vessel types via the same signaling pathway with vessel-specific differences in ADO binding affinity, receptor number, and/or efficiency of the coupling between receptor and G protein or the signaling response. Because the pathways and associated mechanisms underlying the ADO regulation of P s RSA are unclear, we sought by molecular and pharmacological means to determine which receptor subtypes participated in P s RSA responses to ADO, providing fundamental knowledge for the future study of which signaling pathways result in a tighter barrier structure.
P s RSA responses to ADO are mediated mainly by A 2A receptors. To define which ADO receptor subtypes contribute to the alteration of P s RSA in response to ADO suffusion, the nonselective A 1 and A 2 receptor antagonist, 8-SPT, was chosen. 8-SPT is a theophylline derivative that lacks phosphodiesterase inhibition because of negligible intracellular penetration due to its charge at physiological pH (9, 17) . The concentration of 10
Ϫ4
M has been used to identify ADO receptor subtypes responsible for changes in skeletal muscle vascular tone (12, 18, 49) . In the present study, inhibition of A 1 and A 2 receptor with 8-SPT blocked the decreased P s RSA in response to ADO (Fig. 6 ), suggesting that A 1 and/or A 2 but not A 3 receptors mediated the response in both arterioles and venules.
The selective A 1 and A 2A agonists, CPA and CGS21680, respectively, as well as the most-selective A 2B receptor agonist, NECA, were used to determine further the receptor subtypes involved in the ADO response. The pharmacological profile of the ligands revealed that the A 2A receptor agonist CGS21680 was more potent than other ADO analogs ( Fig. 7 ; ADO Ͼ CGS21680 Ͼ CPA Ͼ NECA in arterioles, and ADO ϭ CGS21680 Ͼ CPA ϭ NECA in venules). Of interest, arterioles were more sensitive to ADO [log(IC 50 ) ϭ Ϫ9.8 Ϯ 0.2] than CGS21680 [log(IC 50 ) ϭ Ϫ7.5 Ϯ 1.1]. Two explanations may account for the difference. The first, that the ADO P s RSA response is the net effect of activating both A 1 and A 2A receptors, seems unlikely, as the A 1 agonist CPA alone was without significant effect on arteriolar P s RSA . Second, ADO may alter P s RSA via binding to ADO receptors and use of a nonreceptor-mediated pathway such as an ADO transporter. It has been shown that ADO transporters can take ADO up from smooth muscle intracellular space with a K m of 17.6 Ϯ 2.6 ϫ 10 Ϫ6 M and a V max of 5.1 Ϯ 0.5 ϫ 10 Ϫ12 mol⅐min Ϫ1 ⅐mg wet tissue Ϫ1 in intact porcine coronary artery rings (44) . It is possible that the transported intracellular ADO is converted to AMP, which can activate AMP-activated protein kinase (AMPK), resulting in AMPK-increased nitric oxide (NO) synthesis by stimulation of endothelial NO synthase (eNOS) activity (37) . Had this occurred, an increase in NO would have been expected to elevate, rather than reduce, P s (46) .
The most-selective A 2A receptor antagonist, ZM241385, inhibited P s RSA responses to CGS21680 and ADO (Fig. 8 The current study provides molecular evidence for expression of mRNA and protein for ADO A 1 , A 2A , A 2B , and A 3 receptor subtypes in both arterioles and venules isolated from abdominal skeletal muscles of juvenile female rats. Immunofluorescence analysis demonstrated cellular distribution of ADO A 1 , A 2A , A 2B , and A 3 receptors in the arteriolar and venular microvessels and that all receptor subtypes are located in the inner luminal region consisting of endothelium as well as smooth muscle.
The specific mechanisms whereby A 2A receptor activation results in increased resistance to protein flux from both vessel types require further study. We assume that vascular endothelial cells play a principle role in the regulation of permeability in our preparations, although the wall of our isolated microvessels includes other cell types such as smooth muscle cells, mast cells, and fibroblasts.
Given that ADO A 2A receptors are coupled to the G ␣s protein, ADO binding to A 2A receptors results in the activation of adenylyl cyclase and elevation of cellular cAMP (16, 41) . It is, furthermore, likely that the enhancement of barrier structure is mediated downstream from activation of PKA, because both in vivo and in vitro studies have shown that elevating cAMP levels leads to a reduction in P s (3, 19, 51) . In this study, we demonstrated that inhibition of adenylyl cyclase blocked reduction of P s in response to ADO (Fig. 9) , consistent with the proposal that microvessel barrier resistance by ADO was primarily mediated by the ADO A 2A receptor-adenylyl cyclase pathway. We also found that ADO A 2A receptors exist in arteriolar smooth muscle cells (57 ) . Others have shown that A 2A receptors are expressed on platelets, neutrophils, and mast cells, all of which they are involved in anti-inflammatory activity, especially under ischemic conditions (35) . For instance, activation of A 2A receptors decreased TNF-␣-stimulated neutrophil adherence, oxidative activity, and degranulation (52) . Unfortunately, the contribution of smooth muscle cells and mast cells to the regulation of intact microvessel exchange, specifically P s , cannot be determined directly as yet.
What remains intriguing from this work is that, although all ADO receptor subtypes were found to be present, both as messenger RNA and as expressed protein, only A 2A appeared to be involved in the functional regulation of P s . Preliminary data from sexually mature rats and from microvessels of other tissue beds indicate that a variety of permeability responses occur, implicating involvement of multiple mechanisms in the regulation of exchange in addition to the tightening of the barrier via cAMP-mediated pathways (28, 29) . Comparison of the responses of skeletal muscle vessels from juvenile males and adult rats of both sexes with the present data should provide a useful tool by which the contribution of these other signaling pathways and associated mechanisms can be determined.
In conclusion, the current study is the first to assess rat abdominal skeletal muscle vasculature barrier function in ex-cised, individually perfused microvessels. The findings shed a light on understanding the characteristics of albumin transport across the vascular barrier of skeletal muscle arterioles and venules. The results on P s RSA responses to ADO have physiological and pathophysiological significance, as ADO increases in skeletal muscle under conditions associated with contraction (7), inflammation, and hypoxia as well as ischemia (35) and subsequently affects vascular barrier function. Furthermore, other data from our laboratory indicate fundamental differences in the mechanisms determining fluid homeostasis and its regulation in male and female animals. The clear response to ADO in skeletal muscle microvessels from juvenile female rats provides the basis for a set of quantitative studies to determine the mechanisms underlying sex-based differences in fluid and solute exchange. In addition, the novel findings regarding ADO receptor distribution in rat skeletal muscle microvessels provide a molecular basis for elucidation of the entire role of ADO regulation of microvascular function.
